Genmab | GEN - EPS Earnings Per Share


Genmab reported DKK5.43 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 34.31 26.44 21.70 Aug/07
FY2025Q1 Mar/2025 20.19 16.27 20.18 May/08
FY2024Q4 Dec/2024 59.49 24.90 9.66 Feb/12
FY2024Q3 Sep/2024 19.94 21.70 32.46 Nov/06
FY2024Q2 Jun/2024 21.70 21.35 20.61 Aug/08




Eps Change Date
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Almirall EUR 0.07 0.03 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Demant DKK 6.3 0.2 Jun/2026
Exelixis USD 0.91 0.04 Jun/2026
Fresenius Medical Care EUR 1.12 0.21 Jun/2026
Genmab DKK 5.43 4.6 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
GN Store Nord DKK -1.48 1.17 Jun/2026
GRIFOLS EUR 0.23 0.09 Jun/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Insmed USD -0.06 0.7 Jun/2026
Lakefront Biotherapeutics EUR -0.2 0.64 Jun/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR -0.54 2.65 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
UCB EUR 5.65 3.21 Dec/2025